Sorin aquires Gish Biomedical

Kaitlyn Dmyterko | | Health Imaging | Enterprise Imaging
The Sorin Group has acquired Gish Biomedical from Ventizz Capital Partners, a private equity group.

Rancho Santa Margarita, Calif.-based Gish Biomedical manufactures and distributes disposable medical devices for cardiovascular surgery, according to Sorin, which include vascular access devices and oxygenation systems. Specifically, Michel Darnaud, president of Sorin's cardiopulmonary unit, said that the acqusition was partly due to Gish's extracorporeal circulation devices.

Milan-based Sorin said that the previously outlined market guidance will remain unchanged during the business deal.

Kaitlyn Dmyterko

Related Content

Do large language models help or hinder workflows related to radiology reports?
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI
Radiology practice's communication failure bears tragic consequences
Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.